Maxime Dely: The Vital Role of Plasma-Derived Clotting Factors in Rare Disease Care
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, has shared a post on LinkedIn:
”Clotting factors: when plasma becomes a life-saving medicine
Plasma-derived medicinal products (PDMPs), such as factor VIII or IX concentrates, remain essential for patients living with rare and severe bleeding disorders
Conditions treated:
- Hemophilia A and B (factor VIII or IX deficiency)
- Rare congenital deficiencies (factor V, XI, XIII, protein S, plasminogen…)
- Severe coagulation disorders linked to liver disease, trauma, or critical care situations
Across the world, millions of patients rely every year on plasma-derived medicines when recombinant alternatives are not yet available, effective, or well tolerated.
In many cases, these treatments are the only therapeutic option capable of preventing life-threatening bleeding and enabling a normal quality of life.
Behind every vial of medicine lies a plasma donation — transformed into treatment, hope, and survival for patients facing rare diseases.
How can we raise greater awareness of the vital role that plasma-derived coagulation factors play in rare disease care and innovation?”
Stay updated on the emerging in transfusion medicine with Hemostasis Today.
-
Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
-
Oct 28, 2025, 14:27Maha Othman on 10-Year Anniversary of the CanVECTOR Research Network!
-
Oct 28, 2025, 14:00Claudio Laudani on PCSK9 Association with Increased Platelet Reactivity: A Pooled Analysis
-
Oct 28, 2025, 13:31Laurent Bertoletti Invites You to The INNOVTE and GITA Joined Meeting on Hormones and Thrombosis
-
Oct 28, 2025, 12:28Courtney Lawrence: Honored to Team Up with BET on Blood at AABB 2025
-
Oct 28, 2025, 13:09Gregory Piazza on CORONA-VTE Network Analysis
-
Oct 27, 2025, 18:42Khaled Musallam Shares BEYOND Trial Phase 2 Insights on Luspatercept Use in NTD β-Thalassaemia
-
Oct 27, 2025, 13:30Fabrice Cognasse: When Platelets Meet Artificial Intelligence!
-
Oct 27, 2025, 13:00Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
-
Oct 27, 2025, 09:16Prof. Frank Leebeek: About 20 % of People with Von Willebrand's Disease Have Something Strange Going On
-
Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 27, 2025, 15:10David McIntosh: Making Measurable Progress – Towards a World in Which No-one Ever Dies from Lack of a Vital Plasma-Derived Medicine
-
Oct 27, 2025, 13:18Stroke Foundation Welcomes Jacqui McCallum as the New Executive Director
-
Oct 27, 2025, 12:54Guillermo Lahera Forteza on Stroke and Mental Health
-
Oct 27, 2025, 12:37Joshua Ngimbwa Recognised as the Best Male Junior Investigator Awardee at the Tanzania Health Summit
-
Oct 27, 2025, 09:22Dr. Zsuzsa Bagoly Presents an Overview with Famous People that Suffered from a Stroke